SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4n49'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EIZ_A_SAMA301_0 (FTSJ)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	ALA A 236 PRO A 280 GLY A 281 GLY A 282 LEU A 302 LEU A 383 LYS A 404	SAM A 601 (-3.2A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.6A) SAM A 601 ( 4.1A)	0.62A	1eizA-4n49A: 17.8	1eizA-4n49A: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EJ0_A_SAMA301_0 (FTSJ)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	ALA A 236 PRO A 280 GLY A 281 GLY A 282 LEU A 302 LEU A 383 LYS A 404	SAM A 601 (-3.2A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.6A) SAM A 601 ( 4.1A)	0.58A	1ej0A-4n49A: 17.9	1ej0A-4n49A: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTN_L_TRPL81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 9	VAL A 395 GLY A 357 ALA A 274 THR A 353 ILE A 394	None	1.28A	1gtnL-4n49A: undetectable 1gtnM-4n49A: undetectable	1gtnL-4n49A: 11.49 1gtnM-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HMY_A_SAMA328_0 (HAEIII METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 8	ASP A 335 ILE A 336 THR A 337 LEU A 383	SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 (-4.6A)	0.57A	1hmyA-4n49A: 6.3	1hmyA-4n49A: 20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1O86_A_LPRA702_2 (ANGIOTENSIN CONVERTING ENZYME)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 4	SER A 413 VAL A 481 PHE A 388 VAL A 444	None	1.19A	1o86A-4n49A: undetectable	1o86A-4n49A: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_E_FUAE706_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	THR A 410 SER A 413 LEU A 429 PHE A 158 VAL A 417	None	1.30A	1q23E-4n49A: undetectable	1q23E-4n49A: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B9E_A_SAMA1201_0 (NOL1/NOP2/SUN DOMAIN FAMILY, MEMBER 5 ISOFORM 2)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	CYH A 277 PRO A 280 GLY A 281 LEU A 302 ASP A 335	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.91A	2b9eA-4n49A: 8.7	2b9eA-4n49A: 21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMY_B_SAMB328_0 (PROTEIN (CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI))	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 ASP A 335 ILE A 336 LEU A 383	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 (-4.6A)	0.71A	2hmyB-4n49A: 6.1	2hmyB-4n49A: 20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NYU_B_SAMB201_0 (PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 2)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 281 LEU A 302 THR A 337 LEU A 383 LYS A 404	SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 (-4.6A) SAM A 601 ( 4.1A)	0.73A	2nyuB-4n49A: 15.1	2nyuB-4n49A: 17.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_A_SAMA300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 LEU A 302 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.52A	2oxtA-4n49A: 16.3	2oxtA-4n49A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_B_SAMB300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	6 / 12	GLY A 279 GLY A 281 THR A 301 LEU A 302 ILE A 336 LYS A 404	SAM A 601 (-3.5A) SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 ( 4.1A)	0.66A	2oxtB-4n49A: 16.6	2oxtB-4n49A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_C_SAMC300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	GLY A 279 GLY A 282 THR A 301 LEU A 302 ILE A 336 ASP A 364 LYS A 404	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 ( 4.1A)	0.78A	2oxtC-4n49A: 16.2	2oxtC-4n49A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	6 / 12	ASP A 275 GLY A 279 GLY A 282 THR A 301 LEU A 302 ASP A 364	None SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.60A	2oxtD-4n49A: 14.7	2oxtD-4n49A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PXC_A_SAMA500_0 (GENOME POLYPROTEIN [CONTAINS: CAPSID PROTEIN C (CORE PROTEIN) ENVELOPE PROTEIN M (MATRIX PROTEIN) MAJOR ENVELOPE PROTEIN E NON-STRUCTURAL PROTEIN 1 (NS1) NON-STRUCTURAL PROTEIN 2A (NS2A) FLAVIVIRIN PROTEASE NS2B REGULATORY SUBUNIT FLAVIVIRIN PROTEASE NS3 CATALYTIC SUBUNIT NON-STRUCTURAL PROTEIN 4A (NS4A) NON-STRUCTURAL PROTEIN 4B (NS4B) RNA-DIRECTED RNA POLYMERASE (EC 2.7.7.48) (NS5)])	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.57A	2pxcA-4n49A: 15.1	2pxcA-4n49A: 23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W98_A_P1ZA1352_1 (PROSTAGLANDIN REDUCTASE 2)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 7	LEU A 479 ASN A 478 TYR A 459 LYS A 381	None	1.45A	2w98A-4n49A: 6.7 2w98B-4n49A: 2.5	2w98A-4n49A: 20.81 2w98B-4n49A: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WA2_A_SAMA1248_0 (NON-STRUCTURAL PROTEIN 5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 THR A 301 LEU A 302 ASP A 335 THR A 337	SAM A 601 (-3.5A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 ( 3.9A)	0.60A	2wa2A-4n49A: 16.1	2wa2A-4n49A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WA2_B_SAMB1267_0 (NON-STRUCTURAL PROTEIN 5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 THR A 301 LEU A 302 THR A 337 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 (-3.6A)	0.56A	2wa2B-4n49A: 15.7	2wa2B-4n49A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZMB_A_PXBA692_1 (LACTOTRANSFERRIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	3 / 3	PRO A 149 GLU A 225 TYR A 224	None	0.64A	2zmbA-4n49A: 0.7	2zmbA-4n49A: 20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DOU_A_SAMA1_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	ALA A 236 PRO A 280 GLY A 281 GLY A 282 LEU A 302 ILE A 336 LYS A 404	SAM A 601 (-3.2A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 ( 4.1A)	0.62A	3douA-4n49A: 16.0	3douA-4n49A: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELU_A_SAMA4633_0 (METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 LEU A 302 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.48A	3eluA-4n49A: 15.9	3eluA-4n49A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELW_A_SAMA4633_0 (METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 LEU A 302 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.48A	3elwA-4n49A: 16.2	3elwA-4n49A: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EMB_A_SAMA4633_0 (METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 LEU A 302 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.53A	3embA-4n49A: 16.1	3embA-4n49A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GCZ_A_SAMA4633_0 (POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	6 / 12	GLY A 279 GLY A 282 THR A 301 LEU A 302 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.60A	3gczA-4n49A: 13.7	3gczA-4n49A: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IHT_A_SAMA200_0 (S-ADENOSYL-L-METHION INE METHYL TRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 281 ASP A 335 ILE A 336 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 (-3.6A)	0.76A	3ihtA-4n49A: 7.9	3ihtA-4n49A: 16.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M6V_A_SAMA465_0 (RRNA METHYLASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	PRO A 280 GLY A 281 GLY A 282 ASP A 364 LEU A 383	SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	0.58A	3m6vA-4n49A: 10.2	3m6vA-4n49A: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M6V_B_SAMB465_0 (RRNA METHYLASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	PRO A 280 GLY A 281 GLY A 282 ASP A 364 LEU A 383	SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	0.55A	3m6vB-4n49A: 10.1	3m6vB-4n49A: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3O0M_A_ACTA146_0 (HIT FAMILY PROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 4	ASP A 210 GLU A 212 GLU A 213 ARG A 216	None	0.66A	3o0mA-4n49A: undetectable	3o0mA-4n49A: 16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P5N_A_RBFA190_1 (RIBOFLAVIN UPTAKE PROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	THR A 301 GLY A 365 ALA A 363 LEU A 361 LEU A 383	SAM A 601 (-4.1A) SAM A 601 ( 4.0A) None None SAM A 601 (-4.6A)	1.17A	3p5nA-4n49A: undetectable	3p5nA-4n49A: 19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P5N_B_RBFB190_1 (RIBOFLAVIN UPTAKE PROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	THR A 301 GLY A 365 ALA A 363 LEU A 361 LEU A 383	SAM A 601 (-4.1A) SAM A 601 ( 4.0A) None None SAM A 601 (-4.6A)	1.17A	3p5nB-4n49A: undetectable	3p5nB-4n49A: 19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P97_A_SAMA263_0 (NON-STRUCTURAL PROTEIN 5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.57A	3p97A-4n49A: 15.5	3p97A-4n49A: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P97_C_SAMC263_0 (NON-STRUCTURAL PROTEIN 5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.63A	3p97C-4n49A: 15.7	3p97C-4n49A: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B17_A_SAMA1358_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE M)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	PRO A 280 GLY A 281 GLY A 282 ASP A 335 ASP A 364	SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.70A	4b17A-4n49A: 10.3	4b17A-4n49A: 22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CTJ_A_SAMA1263_0 (NON-STRUCTURAL PROTEIN 5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.55A	4ctjA-4n49A: 15.7	4ctjA-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CTK_A_SAMA1263_0 (POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.58A	4ctkA-4n49A: 15.8	4ctkA-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_A_SAMA401_0 (METHYLTRANSFERASE NSUN4)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	CYH A 277 PRO A 280 GLY A 281 GLY A 282 LEU A 302 ASP A 364 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	0.96A	4fp9A-4n49A: 8.1	4fp9A-4n49A: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_C_SAMC401_0 (METHYLTRANSFERASE NSUN4)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	CYH A 277 PRO A 280 GLY A 281 GLY A 282 LEU A 302 ASP A 364 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	0.97A	4fp9C-4n49A: 8.2	4fp9C-4n49A: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_D_SAMD401_0 (METHYLTRANSFERASE NSUN4)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	CYH A 277 PRO A 280 GLY A 281 GLY A 282 LEU A 302 ASP A 335 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	1.03A	4fp9D-4n49A: 8.4	4fp9D-4n49A: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_F_SAMF401_0 (METHYLTRANSFERASE NSUN4)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	CYH A 277 PRO A 280 GLY A 281 GLY A 282 LEU A 302 ASP A 364 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	0.99A	4fp9F-4n49A: 8.1	4fp9F-4n49A: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FZV_A_SAMA401_0 (PUTATIVE METHYLTRANSFERASE NSUN4)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	7 / 12	CYH A 277 PRO A 280 GLY A 281 GLY A 282 LEU A 302 ASP A 335 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	1.02A	4fzvA-4n49A: 7.9	4fzvA-4n49A: 22.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N48_A_SAMA601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	12 / 12	CYH A 277 GLY A 279 PRO A 280 GLY A 281 PHE A 283 THR A 301 LEU A 302 ASN A 306 ILE A 336 THR A 337 GLY A 365 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.5A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.5A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) None SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 ( 4.0A) SAM A 601 (-4.6A)	0.23A	4n48A-4n49A: 68.2	4n48A-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N48_A_SAMA601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	PRO A 280 LEU A 302 THR A 337 GLY A 366 LEU A 383	SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 (-4.6A) SAM A 601 (-4.6A)	1.10A	4n48A-4n49A: 68.2	4n48A-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 5	ASN A 234 ALA A 236 GLY A 282 ASP A 335 ASP A 364	SAM A 601 (-3.3A) SAM A 601 (-3.2A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.19A	4n48A-4n49A: 68.2	4n48A-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N48_B_SAMB601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	12 / 12	ALA A 236 CYH A 277 GLY A 279 GLY A 281 PHE A 283 THR A 301 LEU A 302 ASN A 306 ILE A 336 THR A 337 GLY A 365 LEU A 383	SAM A 601 (-3.2A) SAM A 601 (-3.7A) SAM A 601 (-3.5A) SAM A 601 (-3.6A) SAM A 601 (-3.5A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) None SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 ( 4.0A) SAM A 601 (-4.6A)	0.23A	4n48B-4n49A: 67.5	4n48B-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N48_B_SAMB601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 5	ASN A 234 PRO A 280 GLY A 282 ASP A 333	SAM A 601 (-3.3A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) None	0.97A	4n48B-4n49A: 67.5	4n48B-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N48_B_SAMB601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 5	ASN A 234 PRO A 280 GLY A 282 ASP A 335 ASP A 364	SAM A 601 (-3.3A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.32A	4n48B-4n49A: 67.5	4n48B-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N49_A_SAMA601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	12 / 12	ALA A 236 CYH A 277 GLY A 279 PRO A 280 GLY A 281 PHE A 283 THR A 301 LEU A 302 ASN A 306 ILE A 336 THR A 337 LEU A 383	SAM A 601 (-3.2A) SAM A 601 (-3.7A) SAM A 601 (-3.5A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-3.5A) SAM A 601 (-4.1A) SAM A 601 (-4.1A) None SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 (-4.6A)	0.00A	4n49A-4n49A: 73.4	4n49A-4n49A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N49_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 4	ASN A 234 GLY A 282 ASP A 335 ASP A 364	SAM A 601 (-3.3A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.01A	4n49A-4n49A: 73.4	4n49A-4n49A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NTX_A_AMRA509_1 (ACID-SENSING ION CHANNEL 1 BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 6	ASP A 333 GLU A 340 ASN A 468 ARG A 471	None	1.06A	4ntxA-4n49A: undetectable 4ntxC-4n49A: undetectable	4ntxA-4n49A: 21.49 4ntxC-4n49A: 14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCK_B_SAMB2409_0 (RNA-DIRECTED RNA POLYMERASE L)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 281 LEU A 302 THR A 337 LYS A 404	SAM A 601 (-3.5A) SAM A 601 (-3.6A) SAM A 601 (-4.1A) SAM A 601 ( 3.9A) SAM A 601 ( 4.1A)	0.79A	4uckB-4n49A: 12.2	4uckB-4n49A: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E9Q_A_SAMA301_0 (GENOME POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.57A	5e9qA-4n49A: 16.0	5e9qA-4n49A: 21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E9Q_C_SAMC4000_0 (GENOME POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.65A	5e9qC-4n49A: 15.2	5e9qC-4n49A: 21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EC8_C_SAMC4000_0 (GENOME POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.59A	5ec8C-4n49A: 15.7	5ec8C-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEU_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5eeuN-4n49A: undetectable 5eeuO-4n49A: undetectable	5eeuN-4n49A: 11.49 5eeuO-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEV_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5eevN-4n49A: undetectable 5eevO-4n49A: undetectable	5eevN-4n49A: 11.49 5eevO-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEW_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5eewN-4n49A: undetectable 5eewO-4n49A: undetectable	5eewN-4n49A: 11.49 5eewO-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEX_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5eexN-4n49A: undetectable 5eexO-4n49A: undetectable	5eexN-4n49A: 11.49 5eexO-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEY_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5eeyN-4n49A: undetectable 5eeyO-4n49A: undetectable	5eeyN-4n49A: 11.49 5eeyO-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EEZ_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5eezN-4n49A: undetectable 5eezO-4n49A: undetectable	5eezN-4n49A: 11.49 5eezO-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF0_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5ef0N-4n49A: undetectable 5ef0O-4n49A: undetectable	5ef0N-4n49A: 11.49 5ef0O-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF1_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5ef1N-4n49A: undetectable 5ef1O-4n49A: undetectable	5ef1N-4n49A: 11.49 5ef1O-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF2_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5ef2N-4n49A: undetectable 5ef2O-4n49A: undetectable	5ef2N-4n49A: 11.49 5ef2O-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF3_O_TRPO101_0 (TRANSCRIPTION ATTENUATION PROTEIN MTRB)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 10	GLY A 357 HIS A 359 ALA A 274 THR A 353 ILE A 394	None	1.46A	5ef3N-4n49A: undetectable 5ef3O-4n49A: undetectable	5ef3N-4n49A: 11.49 5ef3O-4n49A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EHG_A_SAMA301_0 (RNA-DIRECTED RNA POLYMERASE NS5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.54A	5ehgA-4n49A: 13.5	5ehgA-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EHI_A_SAMA4001_0 (NS5 METHYLTRANSFERASE DENGUE VIRUS)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.57A	5ehiA-4n49A: 15.8	5ehiA-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EHI_C_SAMC4000_0 (NS5 METHYLTRANSFERASE DENGUE VIRUS)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.60A	5ehiC-4n49A: 15.3	5ehiC-4n49A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EIF_A_SAMA301_0 (GENOME POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.56A	5eifA-4n49A: 15.7	5eifA-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EIF_C_SAMC4000_0 (GENOME POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.61A	5eifC-4n49A: 15.9	5eifC-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EIW_A_SAMA301_0 (NS5 METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.58A	5eiwA-4n49A: 15.3	5eiwA-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EIW_C_SAMC4000_0 (NS5 METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.56A	5eiwC-4n49A: 15.5	5eiwC-4n49A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EKX_A_SAMA301_0 (NS5 METHYLTRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.56A	5ekxA-4n49A: 15.8	5ekxA-4n49A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKM_A_SAMA311_0 (NS5 METHYL TRANSFERASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.56A	5ikmA-4n49A: 16.0	5ikmA-4n49A: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KQS_A_SAMA307_0 (GENOME POLYPROTEIN)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.56A	5kqsA-4n49A: 15.8	5kqsA-4n49A: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NJV_A_SAMA301_0 (NS5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.56A	5njvA-4n49A: 15.6	5njvA-4n49A: 21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NJV_B_SAMB301_0 (NS5)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.55A	5njvB-4n49A: 14.9	5njvB-4n49A: 21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WWS_A_SAMA501_0 (PUTATIVE METHYLTRANSFERASE NSUN6)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	6 / 12	CYH A 277 PRO A 280 GLY A 282 ASP A 335 ASP A 364 LEU A 383	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A) SAM A 601 (-4.6A)	1.03A	5wwsA-4n49A: 8.5	5wwsA-4n49A: 24.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WWS_B_SAMB501_0 (PUTATIVE METHYLTRANSFERASE NSUN6)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	CYH A 277 PRO A 280 GLY A 282 ASP A 335 ASP A 364	SAM A 601 (-3.7A) SAM A 601 (-3.6A) SAM A 601 (-3.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.64A	5wwsB-4n49A: 9.8	5wwsB-4n49A: 24.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WZ2_A_SAMA601_0 (NS5 MTASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.63A	5wz2A-4n49A: 15.2	5wz2A-4n49A: 21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WZ2_B_SAMB601_0 (NS5 MTASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	5 / 12	GLY A 279 GLY A 282 THR A 301 ASP A 335 ASP A 364	SAM A 601 (-3.5A) SAM A 601 (-3.1A) SAM A 601 (-4.1A) SAM A 601 (-3.6A) SAM A 601 (-3.6A)	0.61A	5wz2B-4n49A: 15.7	5wz2B-4n49A: 21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZW2_A_ACTA511_0 (L-PROLYL-[PEPTIDYL-C ARRIER PROTEIN] DEHYDROGENASE)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	3 / 3	ARG A 346 ILE A 394 SER A 393	None	0.87A	5zw2A-4n49A: undetectable	5zw2A-4n49A: 22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_A_AQ4A602_1 (CYTOCHROME P450 1A1)	4n49	CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1 (Homo sapiens)	4 / 5	ILE A 342 SER A 343 ALA A 462 LEU A 385	None	0.93A	6dwnA-4n49A: undetectable	6dwnA-4n49A: 15.18

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EIZ_A_SAMA301_0","FTSJ","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"ALA A 236;PRO A 280;GLY A 281;GLY A 282;LEU A 302;LEU A 383;LYS A 404","SAM A 601 (-3.2A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.6A);SAM A 601 ( 4.1A)","0.62A","1eizA-4n49A:17.8","1eizA-4n49A:17.84"],["1EJ0_A_SAMA301_0","FTSJ","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"ALA A 236;PRO A 280;GLY A 281;GLY A 282;LEU A 302;LEU A 383;LYS A 404","SAM A 601 (-3.2A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.6A);SAM A 601 ( 4.1A)","0.58A","1ej0A-4n49A:17.9","1ej0A-4n49A:17.84"],["1GTN_L_TRPL81_0","TRP RNA-BINDING ATTENUATION PROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"VAL A 395;GLY A 357;ALA A 274;THR A 353;ILE A 394","None","1.28A","1gtnL-4n49A:undetectable;1gtnM-4n49A:undetectable","1gtnL-4n49A:11.49;1gtnM-4n49A:11.49"],["1HMY_A_SAMA328_0","HAEIII METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"ASP A 335;ILE A 336;THR A 337;LEU A 383","SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 (-4.6A)","0.57A","1hmyA-4n49A:6.3","1hmyA-4n49A:20.36"],["1O86_A_LPRA702_2","ANGIOTENSIN CONVERTING ENZYME","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"SER A 413;VAL A 481;PHE A 388;VAL A 444","None","1.19A","1o86A-4n49A:undetectable","1o86A-4n49A:21.71"],["1Q23_E_FUAE706_1","CHLORAMPHENICOL ACETYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"THR A 410;SER A 413;LEU A 429;PHE A 158;VAL A 417","None","1.30A","1q23E-4n49A:undetectable","1q23E-4n49A:19.10"],["2B9E_A_SAMA1201_0","NOL1\/NOP2\/SUN DOMAIN FAMILY, MEMBER 5 ISOFORM 2","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"CYH A 277;PRO A 280;GLY A 281;LEU A 302;ASP A 335","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.91A","2b9eA-4n49A:8.7","2b9eA-4n49A:21.05"],["2HMY_B_SAMB328_0","PROTEIN (CYTOSINE-SPECIFIC METHYLTRANSFERASE HHAI)","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;ASP A 335;ILE A 336;LEU A 383","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 (-4.6A)","0.71A","2hmyB-4n49A:6.1","2hmyB-4n49A:20.36"],["2NYU_B_SAMB201_0","PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 2","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 281;LEU A 302;THR A 337;LEU A 383;LYS A 404","SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 (-4.6A);SAM A 601 ( 4.1A)","0.73A","2nyuB-4n49A:15.1","2nyuB-4n49A:17.87"],["2OXT_A_SAMA300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;LEU A 302;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.52A","2oxtA-4n49A:16.3","2oxtA-4n49A:21.89"],["2OXT_B_SAMB300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",6,"GLY A 279;GLY A 281;THR A 301;LEU A 302;ILE A 336;LYS A 404","SAM A 601 (-3.5A);SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 ( 4.1A)","0.66A","2oxtB-4n49A:16.6","2oxtB-4n49A:21.89"],["2OXT_C_SAMC300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"GLY A 279;GLY A 282;THR A 301;LEU A 302;ILE A 336;ASP A 364;LYS A 404","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 ( 4.1A)","0.78A","2oxtC-4n49A:16.2","2oxtC-4n49A:21.89"],["2OXT_D_SAMD300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",6,"ASP A 275;GLY A 279;GLY A 282;THR A 301;LEU A 302;ASP A 364","None;SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.60A","2oxtD-4n49A:14.7","2oxtD-4n49A:21.89"],["2PXC_A_SAMA500_0","GENOME POLYPROTEIN [CONTAINS: CAPSID PROTEIN C (CORE PROTEIN); ENVELOPE PROTEIN M (MATRIX PROTEIN); MAJOR ENVELOPE PROTEIN E; NON-STRUCTURAL PROTEIN 1 (NS1); NON-STRUCTURAL PROTEIN 2A (NS2A); FLAVIVIRIN PROTEASE NS2B REGULATORY SUBUNIT; FLAVIVIRIN PROTEASE NS3 CATALYTIC SUBUNIT; NON-STRUCTURAL PROTEIN 4A (NS4A); NON-STRUCTURAL PROTEIN 4B (NS4B); RNA-DIRECTED RNA POLYMERASE (EC 2.7.7.48) (NS5)]","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.57A","2pxcA-4n49A:15.1","2pxcA-4n49A:23.60"],["2W98_A_P1ZA1352_1","PROSTAGLANDIN REDUCTASE 2;PROSTAGLANDIN REDUCTASE 2","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"LEU A 479;ASN A 478;TYR A 459;LYS A 381","None","1.45A","2w98A-4n49A:6.7;2w98B-4n49A:2.5","2w98A-4n49A:20.81;2w98B-4n49A:20.81"],["2WA2_A_SAMA1248_0","NON-STRUCTURAL PROTEIN 5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;THR A 301;LEU A 302;ASP A 335;THR A 337","SAM A 601 (-3.5A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 ( 3.9A)","0.60A","2wa2A-4n49A:16.1","2wa2A-4n49A:22.65"],["2WA2_B_SAMB1267_0","NON-STRUCTURAL PROTEIN 5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;THR A 301;LEU A 302;THR A 337;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 (-3.6A)","0.56A","2wa2B-4n49A:15.7","2wa2B-4n49A:22.65"],["2ZMB_A_PXBA692_1","LACTOTRANSFERRIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",3,"PRO A 149;GLU A 225;TYR A 224","None","0.64A","2zmbA-4n49A:0.7","2zmbA-4n49A:20.43"],["3DOU_A_SAMA1_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"ALA A 236;PRO A 280;GLY A 281;GLY A 282;LEU A 302;ILE A 336;LYS A 404","SAM A 601 (-3.2A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 ( 4.1A)","0.62A","3douA-4n49A:16.0","3douA-4n49A:19.90"],["3ELU_A_SAMA4633_0","METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;LEU A 302;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.48A","3eluA-4n49A:15.9","3eluA-4n49A:undetectable"],["3ELW_A_SAMA4633_0","METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;LEU A 302;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.48A","3elwA-4n49A:16.2","3elwA-4n49A:22.33"],["3EMB_A_SAMA4633_0","METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;LEU A 302;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.53A","3embA-4n49A:16.1","3embA-4n49A:undetectable"],["3GCZ_A_SAMA4633_0","POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",6,"GLY A 279;GLY A 282;THR A 301;LEU A 302;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.60A","3gczA-4n49A:13.7","3gczA-4n49A:20.65"],["3IHT_A_SAMA200_0","S-ADENOSYL-L-METHIONINE METHYL TRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 281;ASP A 335;ILE A 336;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 (-3.6A)","0.76A","3ihtA-4n49A:7.9","3ihtA-4n49A:16.82"],["3M6V_A_SAMA465_0","RRNA METHYLASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"PRO A 280;GLY A 281;GLY A 282;ASP A 364;LEU A 383","SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","0.58A","3m6vA-4n49A:10.2","3m6vA-4n49A:22.64"],["3M6V_B_SAMB465_0","RRNA METHYLASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"PRO A 280;GLY A 281;GLY A 282;ASP A 364;LEU A 383","SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","0.55A","3m6vB-4n49A:10.1","3m6vB-4n49A:22.64"],["3O0M_A_ACTA146_0","HIT FAMILY PROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"ASP A 210;GLU A 212;GLU A 213;ARG A 216","None","0.66A","3o0mA-4n49A:undetectable","3o0mA-4n49A:16.08"],["3P5N_A_RBFA190_1","RIBOFLAVIN UPTAKE PROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"THR A 301;GLY A 365;ALA A 363;LEU A 361;LEU A 383","SAM A 601 (-4.1A);SAM A 601 ( 4.0A);None;None;SAM A 601 (-4.6A)","1.17A","3p5nA-4n49A:undetectable","3p5nA-4n49A:19.42"],["3P5N_B_RBFB190_1","RIBOFLAVIN UPTAKE PROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"THR A 301;GLY A 365;ALA A 363;LEU A 361;LEU A 383","SAM A 601 (-4.1A);SAM A 601 ( 4.0A);None;None;SAM A 601 (-4.6A)","1.17A","3p5nB-4n49A:undetectable","3p5nB-4n49A:19.42"],["3P97_A_SAMA263_0","NON-STRUCTURAL PROTEIN 5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.57A","3p97A-4n49A:15.5","3p97A-4n49A:22.01"],["3P97_C_SAMC263_0","NON-STRUCTURAL PROTEIN 5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.63A","3p97C-4n49A:15.7","3p97C-4n49A:22.01"],["4B17_A_SAMA1358_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE M","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"PRO A 280;GLY A 281;GLY A 282;ASP A 335;ASP A 364","SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.70A","4b17A-4n49A:10.3","4b17A-4n49A:22.47"],["4CTJ_A_SAMA1263_0","NON-STRUCTURAL PROTEIN 5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.55A","4ctjA-4n49A:15.7","4ctjA-4n49A:21.30"],["4CTK_A_SAMA1263_0","POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.58A","4ctkA-4n49A:15.8","4ctkA-4n49A:21.30"],["4FP9_A_SAMA401_0","METHYLTRANSFERASE NSUN4","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"CYH A 277;PRO A 280;GLY A 281;GLY A 282;LEU A 302;ASP A 364;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","0.96A","4fp9A-4n49A:8.1","4fp9A-4n49A:22.64"],["4FP9_C_SAMC401_0","METHYLTRANSFERASE NSUN4","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"CYH A 277;PRO A 280;GLY A 281;GLY A 282;LEU A 302;ASP A 364;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","0.97A","4fp9C-4n49A:8.2","4fp9C-4n49A:22.64"],["4FP9_D_SAMD401_0","METHYLTRANSFERASE NSUN4","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"CYH A 277;PRO A 280;GLY A 281;GLY A 282;LEU A 302;ASP A 335;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","1.03A","4fp9D-4n49A:8.4","4fp9D-4n49A:22.64"],["4FP9_F_SAMF401_0","METHYLTRANSFERASE NSUN4","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"CYH A 277;PRO A 280;GLY A 281;GLY A 282;LEU A 302;ASP A 364;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","0.99A","4fp9F-4n49A:8.1","4fp9F-4n49A:22.64"],["4FZV_A_SAMA401_0","PUTATIVE METHYLTRANSFERASE NSUN4","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",7,"CYH A 277;PRO A 280;GLY A 281;GLY A 282;LEU A 302;ASP A 335;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","1.02A","4fzvA-4n49A:7.9","4fzvA-4n49A:22.54"],["4N48_A_SAMA601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",12,"CYH A 277;GLY A 279;PRO A 280;GLY A 281;PHE A 283;THR A 301;LEU A 302;ASN A 306;ILE A 336;THR A 337;GLY A 365;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.5A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.5A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);None;SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 ( 4.0A);SAM A 601 (-4.6A)","0.23A","4n48A-4n49A:68.2","4n48A-4n49A:100.00"],["4N48_A_SAMA601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"PRO A 280;LEU A 302;THR A 337;GLY A 366;LEU A 383","SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 (-4.6A);SAM A 601 (-4.6A)","1.10A","4n48A-4n49A:68.2","4n48A-4n49A:100.00"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"ASN A 234;ALA A 236;GLY A 282;ASP A 335;ASP A 364","SAM A 601 (-3.3A);SAM A 601 (-3.2A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.19A","4n48A-4n49A:68.2","4n48A-4n49A:100.00"],["4N48_B_SAMB601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",12,"ALA A 236;CYH A 277;GLY A 279;GLY A 281;PHE A 283;THR A 301;LEU A 302;ASN A 306;ILE A 336;THR A 337;GLY A 365;LEU A 383","SAM A 601 (-3.2A);SAM A 601 (-3.7A);SAM A 601 (-3.5A);SAM A 601 (-3.6A);SAM A 601 (-3.5A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);None;SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 ( 4.0A);SAM A 601 (-4.6A)","0.23A","4n48B-4n49A:67.5","4n48B-4n49A:100.00"],["4N48_B_SAMB601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"ASN A 234;PRO A 280;GLY A 282;ASP A 333","SAM A 601 (-3.3A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);None","0.97A","4n48B-4n49A:67.5","4n48B-4n49A:100.00"],["4N48_B_SAMB601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"ASN A 234;PRO A 280;GLY A 282;ASP A 335;ASP A 364","SAM A 601 (-3.3A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.32A","4n48B-4n49A:67.5","4n48B-4n49A:100.00"],["4N49_A_SAMA601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",12,"ALA A 236;CYH A 277;GLY A 279;PRO A 280;GLY A 281;PHE A 283;THR A 301;LEU A 302;ASN A 306;ILE A 336;THR A 337;LEU A 383","SAM A 601 (-3.2A);SAM A 601 (-3.7A);SAM A 601 (-3.5A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-3.5A);SAM A 601 (-4.1A);SAM A 601 (-4.1A);None;SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 (-4.6A)","0.00A","4n49A-4n49A:73.4","4n49A-4n49A:100.00"],["4N49_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"ASN A 234;GLY A 282;ASP A 335;ASP A 364","SAM A 601 (-3.3A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.01A","4n49A-4n49A:73.4","4n49A-4n49A:100.00"],["4NTX_A_AMRA509_1","ACID-SENSING ION CHANNEL 1;BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"ASP A 333;GLU A 340;ASN A 468;ARG A 471","None","1.06A","4ntxA-4n49A:undetectable;4ntxC-4n49A:undetectable","4ntxA-4n49A:21.49;4ntxC-4n49A:14.08"],["4UCK_B_SAMB2409_0","RNA-DIRECTED RNA POLYMERASE L","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 281;LEU A 302;THR A 337;LYS A 404","SAM A 601 (-3.5A);SAM A 601 (-3.6A);SAM A 601 (-4.1A);SAM A 601 ( 3.9A);SAM A 601 ( 4.1A)","0.79A","4uckB-4n49A:12.2","4uckB-4n49A:21.63"],["5E9Q_A_SAMA301_0","GENOME POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.57A","5e9qA-4n49A:16.0","5e9qA-4n49A:21.56"],["5E9Q_C_SAMC4000_0","GENOME POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.65A","5e9qC-4n49A:15.2","5e9qC-4n49A:21.56"],["5EC8_C_SAMC4000_0","GENOME POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.59A","5ec8C-4n49A:15.7","5ec8C-4n49A:21.30"],["5EEU_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5eeuN-4n49A:undetectable;5eeuO-4n49A:undetectable","5eeuN-4n49A:11.49;5eeuO-4n49A:11.49"],["5EEV_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5eevN-4n49A:undetectable;5eevO-4n49A:undetectable","5eevN-4n49A:11.49;5eevO-4n49A:11.49"],["5EEW_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5eewN-4n49A:undetectable;5eewO-4n49A:undetectable","5eewN-4n49A:11.49;5eewO-4n49A:11.49"],["5EEX_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5eexN-4n49A:undetectable;5eexO-4n49A:undetectable","5eexN-4n49A:11.49;5eexO-4n49A:11.49"],["5EEY_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5eeyN-4n49A:undetectable;5eeyO-4n49A:undetectable","5eeyN-4n49A:11.49;5eeyO-4n49A:11.49"],["5EEZ_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5eezN-4n49A:undetectable;5eezO-4n49A:undetectable","5eezN-4n49A:11.49;5eezO-4n49A:11.49"],["5EF0_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5ef0N-4n49A:undetectable;5ef0O-4n49A:undetectable","5ef0N-4n49A:11.49;5ef0O-4n49A:11.49"],["5EF1_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5ef1N-4n49A:undetectable;5ef1O-4n49A:undetectable","5ef1N-4n49A:11.49;5ef1O-4n49A:11.49"],["5EF2_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5ef2N-4n49A:undetectable;5ef2O-4n49A:undetectable","5ef2N-4n49A:11.49;5ef2O-4n49A:11.49"],["5EF3_O_TRPO101_0","TRANSCRIPTION ATTENUATION PROTEIN MTRB","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 357;HIS A 359;ALA A 274;THR A 353;ILE A 394","None","1.46A","5ef3N-4n49A:undetectable;5ef3O-4n49A:undetectable","5ef3N-4n49A:11.49;5ef3O-4n49A:11.49"],["5EHG_A_SAMA301_0","RNA-DIRECTED RNA POLYMERASE NS5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.54A","5ehgA-4n49A:13.5","5ehgA-4n49A:21.30"],["5EHI_A_SAMA4001_0","NS5 METHYLTRANSFERASE DENGUE VIRUS","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.57A","5ehiA-4n49A:15.8","5ehiA-4n49A:21.30"],["5EHI_C_SAMC4000_0","NS5 METHYLTRANSFERASE DENGUE VIRUS","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.60A","5ehiC-4n49A:15.3","5ehiC-4n49A:undetectable"],["5EIF_A_SAMA301_0","GENOME POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.56A","5eifA-4n49A:15.7","5eifA-4n49A:21.30"],["5EIF_C_SAMC4000_0","GENOME POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.61A","5eifC-4n49A:15.9","5eifC-4n49A:21.30"],["5EIW_A_SAMA301_0","NS5 METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.58A","5eiwA-4n49A:15.3","5eiwA-4n49A:21.30"],["5EIW_C_SAMC4000_0","NS5 METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.56A","5eiwC-4n49A:15.5","5eiwC-4n49A:21.30"],["5EKX_A_SAMA301_0","NS5 METHYLTRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.56A","5ekxA-4n49A:15.8","5ekxA-4n49A:undetectable"],["5IKM_A_SAMA311_0","NS5 METHYL TRANSFERASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.56A","5ikmA-4n49A:16.0","5ikmA-4n49A:21.20"],["5KQS_A_SAMA307_0","GENOME POLYPROTEIN","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.56A","5kqsA-4n49A:15.8","5kqsA-4n49A:22.10"],["5NJV_A_SAMA301_0","NS5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.56A","5njvA-4n49A:15.6","5njvA-4n49A:21.97"],["5NJV_B_SAMB301_0","NS5","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.55A","5njvB-4n49A:14.9","5njvB-4n49A:21.97"],["5WWS_A_SAMA501_0","PUTATIVE METHYLTRANSFERASE NSUN6","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",6,"CYH A 277;PRO A 280;GLY A 282;ASP A 335;ASP A 364;LEU A 383","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A);SAM A 601 (-4.6A)","1.03A","5wwsA-4n49A:8.5","5wwsA-4n49A:24.04"],["5WWS_B_SAMB501_0","PUTATIVE METHYLTRANSFERASE NSUN6","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"CYH A 277;PRO A 280;GLY A 282;ASP A 335;ASP A 364","SAM A 601 (-3.7A);SAM A 601 (-3.6A);SAM A 601 (-3.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.64A","5wwsB-4n49A:9.8","5wwsB-4n49A:24.04"],["5WZ2_A_SAMA601_0","NS5 MTASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.63A","5wz2A-4n49A:15.2","5wz2A-4n49A:21.98"],["5WZ2_B_SAMB601_0","NS5 MTASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",5,"GLY A 279;GLY A 282;THR A 301;ASP A 335;ASP A 364","SAM A 601 (-3.5A);SAM A 601 (-3.1A);SAM A 601 (-4.1A);SAM A 601 (-3.6A);SAM A 601 (-3.6A)","0.61A","5wz2B-4n49A:15.7","5wz2B-4n49A:21.98"],["5ZW2_A_ACTA511_0","L-PROLYL-[PEPTIDYL-CARRIER PROTEIN] DEHYDROGENASE","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",3,"ARG A 346;ILE A 394;SER A 393","None","0.87A","5zw2A-4n49A:undetectable","5zw2A-4n49A:22.05"],["6DWN_A_AQ4A602_1","CYTOCHROME P450 1A1","4n49","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","Homo sapiens",4,"ILE A 342;SER A 343;ALA A 462;LEU A 385","None","0.93A","6dwnA-4n49A:undetectable","6dwnA-4n49A:15.18"]]